Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
24.9% overvalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.8% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
9
users have commented on this narrative
24
users have followed this narrative
10 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
5.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
45.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Pivotree
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global E-Commerce And Cloud Trends Will Unlock New Markets
Key Takeaways Growing automation, scalable delivery, and focus on high margin services position Pivotree for rapid operating leverage and sustained earnings expansion. Enhanced sales efficiency, differentiated data solutions, and a resilient financial base enable aggressive growth, especially as digital transformation and AI adoption accelerate.
View narrative
CA$2.75
FV
47.6% undervalued
intrinsic discount
0.0068%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Marley Spoon Group
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Digital Trends And Rising Convenience Will Transform Modern Meal Delivery
Key Takeaways Unique digital platform and diversified product range position Marley Spoon for outsized market share gains and sustained premium margins amid evolving consumer preferences. Advanced data analytics and operational efficiencies are expected to significantly boost customer value, retention, and overall profitability beyond current market expectations.
View narrative
€2.70
FV
85.3% undervalued
intrinsic discount
5.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Biovica International
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Growing Cancer Incidence And AI Will Drive Diagnostic Expansion
Key Takeaways Success in clinical trials and partnerships could accelerate adoption of DiviTum, driving rapid sales growth, recurring revenues, and higher gross margins through scalability and digital integration. Biovica's unique diagnostic position in value-based healthcare and precision oncology enhances its potential for durable premium pricing, industry consolidation, and attractiveness as an acquisition target.
View narrative
SEK 3.00
FV
78.6% undervalued
intrinsic discount
219.22%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Bridgeline Digital
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Digital Transformation And AI Will Drive Secular Expansion
Key Takeaways Upselling to existing customers and AI-driven product innovation are accelerating recurring revenue growth and expanding profit margins beyond market expectations. Elevated marketing and a leading position in B2B search are fueling rapid customer acquisition and setting up sustainable, scalable earnings growth.
View narrative
US$4.62
FV
70.1% undervalued
intrinsic discount
17.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
STRATA Skin Sciences
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Noninvasive Laser Therapies Will Expand Global Dermatology Markets
Key Takeaways Expanded reimbursement and new codes are set to rapidly boost revenue, margins, and patient reach, accelerating growth ahead of earlier expectations. Strategic device offerings and operational models position the company for sustained growth, recurring revenue, and operating leverage in a growing dermatology market.
View narrative
US$12.00
FV
85.4% undervalued
intrinsic discount
8.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Shield Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Digital Marketing And Oral Iron Therapy Will Drive Adoption
Key Takeaways Accelerated digital and influencer marketing, alongside oral-first therapies, could significantly expand market share and net margins beyond current analyst expectations. Strategic geographic launches, pending label expansions, and targeted product acquisitions set the stage for compounded growth and multi-product profitability.
View narrative
UK£0.23
FV
68.9% undervalued
intrinsic discount
78.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Longeveron
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
HLHS Trials And Aging Demographics Will Expand Regenerative Markets
Key Takeaways Strong clinical and regulatory positioning in multiple rare diseases, combined with advantageous designations, bolsters expedited approvals, commercial potential, and recurring revenue streams. Leadership in next-generation regenerative therapies and scalable manufacturing supports long-term growth, pipeline expansion, and improving profitability amid increasing healthcare demand.
View narrative
US$10.45
FV
92.3% undervalued
intrinsic discount
143.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
DarioHealth
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Aging Demographics And Telehealth Will Transform Chronic Care
Key Takeaways Industry-leading outcomes, platform expansion, and entry into new care verticals position DarioHealth for accelerated market share and significant long-term revenue growth. Broad AI integration and premium-based reimbursement unlock major operating efficiencies and new revenue streams, driving margin expansion and improved earnings visibility.
View narrative
US$4.00
FV
86.3% undervalued
intrinsic discount
21.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Starbreeze
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Digital Entertainment Adoption And PAYDAY Expansion Will Redefine Multiplayer Gaming
Key Takeaways Full control of the PAYDAY franchise and expansion into new media are set to drive higher recurring, high-margin revenues and long-term brand value. New leadership and digital distribution focus position Starbreeze to scale live-service monetization and global reach beyond current market expectations.
View narrative
SEK 0.45
FV
59.4% undervalued
intrinsic discount
14.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies